Natus Medical shares soar toward a 2-year high after deal to be acquired at a 29% premium by ArchiMed
Shares of Natus Medical Inc. shot up 28.1% to pace all premarket gainers Monday, after the medical device company announced an agreement to be acquired in a deal valued at $1.2 billion by an affiliate of investment firm ArchiMed. Under terms of the deal, ArchiMed will pay $33.50 in cash for each Natus Medical share outstanding, representing a 28.6% premium to Thursday's closing price of $26.05. And the company will have a 30-day go-shop period in which it can solicit proposals from third parties. Читать дальше...